The evolution of drug discovery: from phenotypes to targets, and back
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The evolution of drug discovery: from phenotypes to targets, and back
Authors
Keywords
-
Journal
MedChemComm
Volume 7, Issue 5, Pages 788-798
Publisher
Royal Society of Chemistry (RSC)
Online
2016-03-30
DOI
10.1039/c6md00129g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropharmacology beyond reductionism – A likely prospect
- (2016) Doru Georg Margineanu BIOSYSTEMS
- Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives
- (2016) Krishna C. Bulusu et al. DRUG DISCOVERY TODAY
- Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
- (2015) Hassan Al-Ali et al. ACS Chemical Biology
- Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology
- (2015) Brendan Frett et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes
- (2015) Fabian Alexander Grimm et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles
- (2015) Agnieszka Szwajda et al. CHEMISTRY & BIOLOGY
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- Pioneering government-sponsored drug repositioning collaborations: progress and learning
- (2015) Donald E. Frail et al. NATURE REVIEWS DRUG DISCOVERY
- “The future of in vitro toxicology”
- (2015) Paul Jennings TOXICOLOGY IN VITRO
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- SIRT7 Controls Hepatic Lipid Metabolism by Regulating the Ubiquitin-Proteasome Pathway
- (2014) Tatsuya Yoshizawa et al. Cell Metabolism
- Spinal Cord Regeneration
- (2014) Wise Young CELL TRANSPLANTATION
- An overview of FDA-approved new molecular entities: 1827–2013
- (2014) Michael S. Kinch et al. DRUG DISCOVERY TODAY
- Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families
- (2014) Matthew G. Rees et al. HUMAN MOLECULAR GENETICS
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- The discovery of first-in-class drugs: origins and evolution
- (2014) Jörg Eder et al. NATURE REVIEWS DRUG DISCOVERY
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
- (2014) Lesley A. Mathews Griner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exploiting polypharmacology for drug target deconvolution
- (2014) Taranjit Singh Gujral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Target control of complex networks
- (2014) Jianxi Gao et al. Nature Communications
- Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish
- (2014) Giancarlo Bruni et al. Frontiers in Pharmacology
- Chemical Interrogation of the Neuronal Kinome Using a Primary Cell-Based Screening Assay
- (2013) Hassan Al-Ali et al. ACS Chemical Biology
- A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery
- (2013) Yinghong Gao et al. BIOCHEMICAL JOURNAL
- Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
- (2013) D C Swinney CLINICAL PHARMACOLOGY & THERAPEUTICS
- Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
- (2013) Guangxu Jin et al. DRUG DISCOVERY TODAY
- Activity profile relationships between structurally similar promiscuous compounds
- (2013) Ye Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Addressing Selective Polypharmacology of Antipsychotic Drugs Targeting the Bioaminergic Receptors through Receptor Dynamic Conformational Ensembles
- (2013) Balaji Selvam et al. Journal of Chemical Information and Modeling
- Polypharmacology – Foe or Friend?
- (2013) Jens-Uwe Peters JOURNAL OF MEDICINAL CHEMISTRY
- Calculated treatment
- (2013) Natalia L. Komarova et al. NATURE
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
- (2012) Ahmed Temirak et al. Anti-Cancer Agents in Medicinal Chemistry
- Abstract 2547: NCI-60 combination screening matrix of approved anticancer drugs
- (2012) Susan L. Holbeck et al. CANCER RESEARCH
- Comparing Measures of Promiscuity and Exploring Their Relationship to Toxicity
- (2012) Xiangyun Wang et al. Molecular Informatics
- Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
- (2012) Arvin C. Dar et al. NATURE
- Using transcriptome sequencing to identify mechanisms of drug action and resistance
- (2012) Sarah A Wacker et al. Nature Chemical Biology
- Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
- (2012) Joanne Bowes et al. NATURE REVIEWS DRUG DISCOVERY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- On the origins of drug polypharmacology
- (2012) Xavier Jalencas et al. MedChemComm
- Chemical Genetics–Based Target Identification in Drug Discovery
- (2011) Feng Cong et al. Annual Review of Pharmacology and Toxicology
- Design of Multitarget Activity Landscapes That Capture Hierarchical Activity Cliff Distributions
- (2011) Dilyana Dimova et al. Journal of Chemical Information and Modeling
- Controllability of complex networks
- (2011) Yang-Yu Liu et al. NATURE
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Navigating the kinome
- (2011) James T Metz et al. Nature Chemical Biology
- Bugs, drugs and chemical genomics
- (2011) Terry Roemer et al. Nature Chemical Biology
- Networking for new drugs
- (2011) Claire Ainsworth NATURE MEDICINE
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
- (2010) J A DiMasi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009
- (2010) K I Kaitin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
- (2010) Shivanni Kummar et al. NATURE REVIEWS DRUG DISCOVERY
- High-content screening of primary neurons: ready for prime time
- (2009) Aaron Daub et al. CURRENT OPINION IN NEUROBIOLOGY
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- Prediction of protein-glucose binding sites using support vector machines
- (2009) Houssam Nassif et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
- (2008) Beth Apsel et al. Nature Chemical Biology
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More